Comparative in vitro effects of liposomal amphotericin B, amphotericin B-deoxycholate, and free amphotericin B against fungal strains determined by using MIC and minimal lethal concentration susceptibility studies and time-kill curves.
about
Pharmacokinetics and pharmacodynamics of antifungals in children: clinical implicationsComparative neurotoxicities of amphotericin B and its mono-methyl ester derivative in ratsNon-invasive detection of antibiotics and physiological substances in the aqueous humor by Raman spectroscopy.In vitro and in vivo antifungal activity of amphotericin B lipid complex: are phospholipases important?Comparison of in vitro antifungal activities of free and liposome-encapsulated nystatin with those of four amphotericin B formulationsTreatment of murine candidiasis and cryptococcosis with amphotericin B incorporated into egg lecithin-bile salt mixed micelles.Carrier effects on biological activity of amphotericin B.Pharmacokinetics of antifungal agents in children.Susceptibility testing of Candida albicans and Aspergillus species by a simple microtiter menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay.Efficacy and safety of amphotericin B colloidal dispersion compared with those of amphotericin B deoxycholate suspension for treatment of disseminated murine cryptococcosis.Pharmacokinetic profile of ABELCET (amphotericin B lipid complex injection): combined experience from phase I and phase II studiesComparison of antifungal activity of amphotericin B deoxycholate suspension with that of amphotericin B cholesteryl sulfate colloidal dispersion.Clinical evaluation of a new lipid-based delivery system for intravenous administration of amphotericin B.Modulation of amphotericin B activity by association with mannose ester.Enhanced Killing and Antibiofilm Activity of Encapsulated Cinnamaldehyde against Candida albicans.
P2860
Q27025299-03876BA0-B985-400B-9368-8A6F2E13F2F9Q28378621-4642D4BB-CFCC-489D-BB70-0FEE4A8F03FBQ33245219-5059AA07-F4D5-420E-A372-DA15C91DF461Q33692198-37C8C010-C68F-45A3-A736-13DBB3A3F21FQ33693450-453A2DEF-EE70-4944-AF51-98FD689DDD6CQ33749073-EE974064-8AF6-4A52-A846-15E189F74463Q35372581-4DF5A3EE-CCB3-4E57-82F9-586692CFC1ACQ36163345-34A98D77-BF27-4895-B02F-55FAC0ED21CCQ36519575-4EF65BA3-6C2C-410B-B48E-4453E68793C3Q36758184-2CA3FD8B-056C-43A6-B08F-23A7DB4DE431Q39785066-79DECDD5-6A88-4665-81B3-893F7D1D76D8Q39868009-21DF4083-3611-4FC4-B438-DFB0FC18F82CQ40730943-FF0B1F2A-84AE-47D1-BE18-A360AE8947ABQ41452863-CBC0D7E8-717B-4BA0-B0E4-393B8CE830F8Q47149925-4E4EB4E7-CA5D-49EB-9681-EEFBFCC568C3
P2860
Comparative in vitro effects of liposomal amphotericin B, amphotericin B-deoxycholate, and free amphotericin B against fungal strains determined by using MIC and minimal lethal concentration susceptibility studies and time-kill curves.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Comparative in vitro effects o ...... studies and time-kill curves.
@en
type
label
Comparative in vitro effects o ...... studies and time-kill curves.
@en
prefLabel
Comparative in vitro effects o ...... studies and time-kill curves.
@en
P2093
P2860
P356
P1476
Comparative in vitro effects o ...... studies and time-kill curves.
@en
P2093
P2860
P304
P356
10.1128/AAC.35.1.188
P407
P577
1991-01-01T00:00:00Z